139 — Binghamton, New York

139 is a clinical research site located in Binghamton, New York, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

139 has participated in 1 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Binghamton

Browse all research sites in New York · View every site in Binghamton

• Ascension - Our Lady of Lourdes Memorial Hospital
• Guthrie - Our Lady of Lourdes Memorial Hospital
• University Health Service Hospitals, Inc.
• Binghamton University - Motion Analysis Laboratory
• United Health Services Hospitals, Inc.
• Lourdes Hospital Breast Center
• Our Lady of Lourdes Memorial Hospital
• Binghamton University
• Our Lady of Lourdes Hospital
• Lourdes Hospital
• United Medical Associates
• Meridian Clinical Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 139?

139 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 139 conducted?

139 has 1 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 139 accredited by Crixeo Clinical Trials?

139 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 139?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.